ELISHEVA MILLER: Open Payments
NPI 1669409348 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,963 in 131 payments from 15 companies in 2025. Trend: 2023 $1,430 · 2024 $2,895 · 2025 $1,963
Food & beverage: $1,950Education: $13
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 24 | $443 |
| Novartis Pharmaceuticals Corporation | 27 | $341 |
| Galderma Laboratories, L.P. | 16 | $238 |
| PFIZER INC. | 15 | $188 |
| LEO Pharma Inc. | 10 | $172 |
| ABBVIE INC. | 13 | $169 |
| Janssen Biotech, Inc. | 10 | $148 |
| GENZYME CORPORATION | 3 | $55 |
| Organon LLC | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
Products named: OPZELURA, NEMLUVIO, CIBINQO, COSENTYX, TREMFYA, ADBRY, Rhapsido, RINVOQ.
Industry payments across NJ — which companies pay providers there.
